Peter Gebauer

Title: Peter Gebauer - Innovator in Chemical Compounds

Introduction

Peter Gebauer, located in Penzberg, Germany, is a notable inventor with an impressive portfolio of five patented innovations. His work primarily focuses on chemical compounds and their applications in various fields, including diagnostics and analytical chemistry.

Latest Patents

Among his latest patents, two remarkable innovations stand out. The first is related to redox indicators, which encompass a range of chemical compounds derived from phenazine, phenanthridine, and other heterocycles. This invention comprises a conjugated π-system with a π-acceptor group, along with a chemistry matrix and test elements that enable the determination of analyte amounts in test samples based on redox equivalents.

The second patent involves phenazinium mediators, specifically a 1-amino-phenazine derivative. This invention also includes a chemistry matrix and a test element designed for the analysis of liquid samples. The methodology allows for the estimation of the analyte concentration by monitoring the electrons exchanged during the interaction of the sample with the chemistry matrix.

Career Highlights

Peter has made significant contributions while working at renowned companies, including Roche Diagnostics Operations, Inc. and Roche Diabetes Care, Inc. His expertise in chemical innovations has driven advancements in diagnostic technologies, showcasing his commitment to enhancing analytical methods.

Collaborations

Throughout his career, Peter collaborated with distinguished colleagues such as Dieter Heindl and Carina Horn. These collaborations have fostered a productive environment for innovation, allowing for the development of cutting-edge technologies in the field of chemical analysis.

Conclusion

Peter Gebauer's inventions and patents reflect his dedication to advancing the field of chemistry. His innovations, particularly in redox indicators and phenazinium mediators, contribute significantly to scientific research and practical applications in diagnostics. With a solid track record and continued collaboration with other experts, his influence on the industry is sure to grow.